IRIS

Acetonitrile

CASRN 75-05-8 | DTXSID7020009

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (23 pp, 165 K) Last Updated: 03/03/1999
Information reviewed but value not estimated.

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (23 pp, 165 K) Last Updated: 03/03/1999

System RfC (mg/m3) Basis PoD Composite UF Confidence
Other 6 x 10 -2 Mortality NOAEL (HEC): 6.0 x 101
mg/m3
100
MF: 10
Medium

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (23 pp, 165 K) Last Updated: 03/03/1999

WOE Characterization Framework for WOE Characterization
D (Not classifiable as to human carcinogenicity) Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986)
Carcinogenic potential cannot be determined Proposed Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1996)
Basis:
  • Under the Proposed Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1996), the carcinogenic potential of ACN following inhalation, oral, or dermal exposure is best characterized as "cannot be determined because the existing evidence is composed of conflicting data (e.g., some evidence is suggestive of carcinogenic effects, but other equally pertinent evidence does not confirm any concern)."
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (23 pp, 165 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (23 pp, 165 K)

Not assessed under the IRIS Program.


Additional EPA toxicity information may be available by visiting the following sites:

You will need Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more.

Contact Us to ask a question, provide feedback or report a problem.